在补偿性心跳动中服用腺素后心脏骤停:一个病例报告
Craig R Torres-Ness1,2, Sonia A Desai2
1Emergency Medicine, University of Southern California Keck School of Medicine, Los Angeles, USA.
Cureus
|February 26, 2024
概括
紧急医疗服务 (EMS) 误解心电图 (EKG) 导致了腺的滥用,导致肺栓塞患者的心脏骤停. 这一案例凸显了在不合适的场景中使用腺的风险.
科学领域:
- 紧急医疗 紧急医疗
- 心脏病学 心脏病学
- 肺部病理学 肺部病理学
背景情况:
- 由于压力因素导致心率升高的补偿性心跳动,需要谨慎的治疗方法.
- 在医院前环境中误解心电图 (EKG) 存在重大临床风险.
- 氨酸是 Paroxysmal supraventricular tachycardia (PSVT) 的标准治疗方法,但如果滥用,可能会带来风险.
研究的目的:
- 由于误解补偿性心力衰竭为PSVT,报告在腺注射后心脏骤停的病例.
- 强调在紧急医疗服务 (EMS) 中滥用腺的潜在危险.
- 提高人们对医院前心电图解释的挑战的认识.
主要方法:
- 病例报告详细介绍了一种涉及EMS治疗的临床场景.
- 检查患者的表现,心电图的结果,以及随后的诊断.
- 在enosine 给药后发生的不良事件的分析.
主要成果:
- 根据心电图,EMS错误地诊断了补偿性心力衰竭作为PSVT.
- 腺素的使用导致心脏骤停.
- 这名患者后来被诊断出患有肺栓塞,这是心动减速的根本原因.
结论:
- 电脑心电图被EMS误解可能导致不适当和危险的干预措施,如腺注射.
- 这一案例强调了对准确的医院前心电图解释的急需,以防止患者的不良结果.
- 虽然腺对PSVT是安全的,但在肺栓塞等疾病中滥用它可能是致命的.
相关概念视频
Disturbances in Heart Rhythm
956
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
956
Increased pulse rate
664
Tachycardia is a condition marked by an abnormally fast or irregular heart rate, surpassing the typical resting rate. In adults, tachycardia is characterized by a pulse rate ranging from 100 to 180 beats per minute. The increased heart rate can result in inadequate blood flow to various body parts, ultimately diminishing the oxygen supply to organs and tissues.
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
664
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
744
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
744
Mechanism of Cardiac Arrhythmias
920
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
920
ECG Interpretation of Arrhythmias I: Sinus Arrhythmias
215
Arrhythmias are disturbances in the heart's rhythm that lead to abnormal heartbeats. These irregularities can originate from different parts of the heart and are classified based on their origin and nature.
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism,...
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism,...
215
Heart Failure Drugs: Inotropic Agents
588
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
588


